Cargando…

Prognostic role of METTL1 in glioma

BACKGROUND: Current treatment options for glioma are limited, and the prognosis of patients with glioma is poor as the available drugs show low therapeutic efficacy. Furthermore, the molecular mechanisms associated with glioma remain poorly understood. METTL1 mainly catalyzes the formation of N(7)-m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lun, Yang, Yi, Wang, Zhenshuang, Xu, Chengran, Huang, Jinhai, Li, Guangyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627054/ https://www.ncbi.nlm.nih.gov/pubmed/34838021 http://dx.doi.org/10.1186/s12935-021-02346-4

Ejemplares similares

Expression and prognostic potential of ribosome 18S RNA m(6)A methyltransferase METTL5 in gastric cancer
por: Wang, Zhenshuang, et al.
Publicado: (2021)

Increased Expression of Homeobox 5 Predicts Poor Prognosis: A Potential Prognostic Biomarker for Glioma
por: Xu, Chengran, et al.
Publicado: (2022)

METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis
por: Jiang, Zhipeng, et al.
Publicado: (2021)

Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database
por: Yang, Yi, et al.
Publicado: (2020)

Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma
por: Wang, Yi, et al.
Publicado: (2021)

Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy
por: Xu, Houshi, et al.
Publicado: (2021)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

Systematically profiling the expression of eIF3 subunits in glioma reveals the expression of eIF3i has prognostic value in IDH-mutant lower grade glioma
por: Chai, Rui-Chao, et al.
Publicado: (2019)

Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma
por: Wu, Fan, et al.
Publicado: (2018)

MiR-4310 induced by SP1 targets PTEN to promote glioma progression
por: Wu, Zhiyong, et al.
Publicado: (2020)

METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification
por: Xu, Yiming, et al.
Publicado: (2022)

LINC01605, regulated by the EP300-SMYD2 complex, potentiates the binding between METTL3 and SPTBN2 in colorectal cancer
por: Yue, Meng, et al.
Publicado: (2021)

Targeting SNHG3/miR-186-5p reverses the increased m6A level caused by platinum treatment through regulating METTL3 in esophageal cancer
por: Zhang, Mingxin, et al.
Publicado: (2021)

METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
por: Shu, Xin, et al.
Publicado: (2021)

Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
por: Liu, Gao-Min, et al.
Publicado: (2019)

Bufalin induces mitochondrial dysfunction and promotes apoptosis of glioma cells by regulating Annexin A2 and DRP1 protein expression
por: Li, Yao, et al.
Publicado: (2021)

An insertion variant of MGMT disrupts a STAT1 binding site and confers susceptibility to glioma
por: Huang, Liming, et al.
Publicado: (2021)

ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2(Q607R)
por: Zhang, Ying, et al.
Publicado: (2018)

The characteristics of bone marrow-derived endothelial progenitor cells and their effect on glioma
por: Zhang, She-Hong, et al.
Publicado: (2012)

The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis
por: Zhao, Chengpeng, et al.
Publicado: (2021)

Patient-derived xenografts of different grade gliomas retain the heterogeneous histological and genetic features of human gliomas
por: Zeng, Wenxin, et al.
Publicado: (2020)

SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
por: Wang, Xizhao, et al.
Publicado: (2019)

MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB
por: Li, Yangyang, et al.
Publicado: (2019)

The predictive and prognostic role of a novel ADS score in esophageal squamous cell carcinoma patients undergoing esophagectomy
por: Gao, Qiu-Fang, et al.
Publicado: (2018)

Skp2 modulates proliferation, senescence and tumorigenesis of glioma
por: Wu, Juan, et al.
Publicado: (2020)

Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling
por: Deng, Shuangya, et al.
Publicado: (2021)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway
por: Li, Huixia, et al.
Publicado: (2020)

CTLA-4 correlates with immune and clinical characteristics of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma
por: Zhang, Yi, et al.
Publicado: (2021)

The histone demethylase JMJD2A promotes glioma cell growth via targeting Akt-mTOR signaling
por: Li, Min, et al.
Publicado: (2020)

MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma
por: Zhang, Jun-feng, et al.
Publicado: (2018)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Prognostic role of pretreatment blood lymphocyte count in patients with solid tumors: a systematic review and meta-analysis
por: Zhao, Jiawen, et al.
Publicado: (2020)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Prognostic role of alternative splicing events in head and neck squamous cell carcinoma
por: Ding, Yanni, et al.
Publicado: (2020)

Prognostic role of galectin-3 expression in patients with solid tumors: a meta-analysis of 36 eligible studies
por: Wang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6jjoeocuvat7vncd9bcs6lg0ol